Journal
PHARMACOGENETICS
Volume 12, Issue 1, Pages 55-65Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00008571-200201000-00008
Keywords
fasting; circadian; microarray; expression
Funding
- NEI NIH HHS [R01 EY002414] Funding Source: Medline
- NHLBI NIH HHS [HL58411, U01 HL66579] Funding Source: Medline
- NATIONAL EYE INSTITUTE [R01EY002414] Funding Source: NIH RePORTER
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058411, U01HL066579] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Pharmacogenomics offers the potential to define metabolic pathways and to provide increased knowledge of drug actions. We studied relative levels of gene expression in the rat using a microarray with 8448 rat UniGenes (1928 known genes, 6520 unknown ESTs) in the liver and kidney as a function of time of day and then of feeding regime, which are common variables in preclinical pharmacogenomic studies. We identified 597 genes, including several key metabolic pathways, whose relative expression levels are significantly affected by time of day: expression of some was further modified by feeding state. These would have sparked interest in a pharmacogenomic study. Our study demonstrates that two common variables in pharmacogenomic studies can have dramatic effects on gene expression. This study provides investigators with baseline information for both kidney and liver with respect to 'normal' changes in gene expression influenced by time of day and feeding state. It also identifies 18 new genes that should be investigated for a role in circadian rhythms in peripheral tissues. Pharmacogenetics 12:55-65 (C) 2002 Lippincott Williams Wilkins.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available